The stock of Manitex Capital Inc. (CVE:MNX) is a huge mover today! About 36,000 shares traded hands or 1957.14% up from the average. Manitex Capital Inc. (CVE:MNX) has risen 6.00% since October 5, 2016 and is uptrending. It has outperformed by 4.91% the S&P500.
The move comes after 5 months positive chart setup for the $3.68 million company. It was reported on Nov, 4 by Barchart.com. We have $0.93 PT which if reached, will make CVE:MNX worth $6.11M more.
More recent Manitex Capital Inc. (CVE:MNX) news were published by: Marketwatch.com which released: “Manitex Capital Inc. acquires convertible debentures of Cold Water Fisheries …” on September 22, 2016. Also Marketwatch.com published the news titled: “Manitex Capital Inc. announces that Valeo Pharma Inc. sold its dermatology …” on August 25, 2014. Marketwired.com‘s news article titled: “Manitex International, Inc. Will Participate in RBC Capital Markets’ Global …” with publication date: August 25, 2016 was also an interesting one.
Manitex Capital Inc. is a Canada-based firm that specializes in acquiring interests in companies and participates in increasing shareholder value in these businesses. The company has a market cap of $3.68 million. The Firm operates through three divisions: diversified investments , biotechnology (biotech) and a pharmaceutical business (pharma). It currently has negative earnings. The investment segment holds interests in companies in the life science industry and also invests in marketable securities.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.